Study Conduct

Align Biopharma launched as industry standards group

Monday, January 30, 2017

Six of the top 25 largest global pharmaceutical companies announced the formation of Align Biopharma, a new group dedicated to setting technology standards that will make it faster and easier for healthcare professionals (HCPs) to connect with the life sciences industry. Founding members, with input from across the industry, will develop open standards and solutions for companies to streamline how HCPs get the drug and treatment information they need to deliver improved care to patients.

[Read More]

PhRMA launches media initiative

Tuesday, January 24, 2017

The Pharmaceutical Research and Manufacturers of America (PhRMA) has launched a national, multi-year advertising and public affairs initiative on behalf of America’s biopharmaceutical companies. The campaign, GOBOLDLY, will showcase the industry’s unsung heroes driving cutting-edge advances in science and highlight the tremendous opportunity that exists to tackle our most complex and devastating health conditions. 

[Read More]

DaVita, Prism choose Verified Clinical Trials to prevent duplicate enrollment

Friday, January 20, 2017

DaVita Clinical Research (DCR), a specialty CRO with services spanning the full spectrum of drug and device development, and Prism Clinical Research, a provider of fully integrated clinical research services to pharma/device companies and clinicians, have announced Verified Clinical Trials (VCT) has been selected by both companies as an exclusive provider to further prevent duplicate enrollment in clinical trials.

[Read More]

Interface Clinical Research launches new clinical trials model

Wednesday, January 18, 2017

New clinical trials company Interface Clinical Research outlined a new model for running primary care clinical trials. Interface will work in partnership with GP practices across the U.K. to deliver large numbers of suitable patients for phase III and IV clinical trials. Typically, 48% of sites used in a clinical trial fail to recruit a single patient. Interface believe they have the capability to recruit hundreds of patients per site.

[Read More]

Report: Poor physician/nurse engagement contributes to low patient recruitment rates

Tuesday, January 17, 2017

Although physicians and nurses are familiar with, and comfortable discussing, clinical trials, they refer a mere fraction of their patients for these studies, reflecting, in part, a failure by sponsors, CROs and investigative site personnel to engage health care providers as partners in the clinical research process, according to a recently completed analysis conducted by the Tufts Center for the Study of Drug Development.

[Read More]

Malecare launches trial accrual system Cancergraph

Tuesday, January 17, 2017

Malecare, a U.S. men’s cancer survivor support and advocacy national nonprofit organization, launched Cancergraph, a mobile application that tracks cancer symptoms, disease states and quality of life reports in real time and quickly identified its primary value as a clinical trial accrual system. Cancergraph distills each users’ health data to provide, in real time, only the specific cancer trials that apply to them. 

[Read More]

Philips, Illumina partner on integrated genomics solutions for oncology

Monday, January 9, 2017

Royal Philips, a global leader in health technology, and Illumina, a global leader in DNA sequencing and array-based technologies, has announced a strategic collaboration that aims to integrate Illumina’s sequencing systems for large-scale analysis of genetic variation and function and Philips’ IntelliSpace Genomics clinical informatics platform, and to coordinate marketing and sales of the resulting solutions. Philips and Illumina will also seek to engage in clinical research collaborations with health systems in the U.S. that want to develop precision medicine programs in oncology.

[Read More]

ACRES, Task Force Dagger Foundation partner

Monday, January 9, 2017

Task Force Dagger Foundation (TFD) Managing Director Keith David and the Alliance for Clinical Research Excellence and Safety (ACRES) President and CEO Greg Koski announced that their nonprofit charitable organizations have established a strategic alliance to address the grave health challenges impacting America’s elite special operations forces and their families through application of ACRES systems-based approaches to accelerate research and advance integrated care.   

[Read More]